Scandion Oncology announces that its President & CEO has bought 10,800 shares in Scandion Oncology
Scandion Oncology A/S (“Scandion Oncology”) announces that its President & CEO, Bo Rode Hansen, has bought additional 10,800 shares in Scandion Oncology resulting in a total holding on 35,900 shares in the Company.For further information, please contact: Bo Rode Hansen, President & CEO Phone: +45 3810 2017 E-mail: info@scandiononcology.com Website: www.scandiononcology.com The information was provided by the contact person above for publication, on July 5, 2021 at 16:30 p.m. CEST. About Scandion Oncology A/S Scandion Oncology is a clinical Phase II biotechnology company